2024-09-12 23:31:27
RIYADH, Saudi Arabia, Sept. 12, 2024 (GLOBE NEWSWIRE) — King Faisal Specialist Hospital & Research Centre (KFSH&RC) is revolutionizing infectious disease diagnostics with Whole Genome Sequencing (WGS) and metagenomic protocols. The new tools enable unmatched accuracy and speed in identifying pathogens, even in the most complex cases.
KFSHRC’s WGS technology enables comprehensive genetic analysis, facilitating early detection of rare mutations and leading to targeted treatments that significantly improve patient outcomes. Complementing WGS, KFSHRC’s metagenomics protocol excels in diagnosing infectious diseases undetectable by conventional methods. By thoroughly analyzing microbial DNA, this protocol has identified pathogens in patients with unexplained symptoms or unresponsive to treatment, revealing previously undiagnosed pathogens in more than half of the cases examined.
The integration of AI with robotics further enhances diagnostic accuracy and surgical precision, contributing to reduced recovery times and improved patient care. In 2023, over 7,000 WGS tests were performed. KFSHRC’s advances are also demonstrated by a 67% reduction in WGS costs, expanded access to genetic testing, and a five-fold increase in analytical capacity. The metagenomic protocol provides rapid results within 24 hours, enabling simultaneous detection of multiple pathogens, including those that are difficult to identify traditionally.
Using these genomic technologies, the KFSHRC is setting new global standards for the diagnosis and treatment of infectious diseases, contributing to improved patient outcomes worldwide.
It is worth noting that King Faisal Specialist Hospital & Research Centre has been ranked first in the Middle East and Africa and 20th worldwide in the list of Top 250 Academic Medical Centers for the second consecutive year. This recognition is a testament to KFSHRC’s commitment to excellence and should instill confidence in the institution’s credibility. Furthermore, in the same year, it was ranked among the Top 250 Hospitals in the World by the prestigious Newsweek magazine, further solidifying its position as a global leader in the healthcare sector.
Media Contact:
Essam AlZahrani
+966 55 525 4429
[email protected]
Photo of this statement available at:
GLOBENEWSWIRE (Distribution ID 9230217)
1726208841
#KFSHRC #Leads #Infectious #Disease #Diagnostics #Advanced #Genomic #Technologies
Table of Contents
- 1 Here are some People Also Ask (PAA) questions related to the title “Revolutionizing Infectious Disease Diagnostics: King Faisal Specialist Hospital & Research Centre Leads the Way”:
- 2 Here are some PAA (People Also Ask) related questions for the title: **Revolutionizing Infectious Disease Diagnostics: King Faisal Specialist Hospital & Research Centre Leads the Way**:
Revolutionizing Infectious Disease Diagnostics: King Faisal Specialist Hospital & Research Centre Leads the Way
In a groundbreaking achievement, King Faisal Specialist Hospital & Research Centre (KFSH&RC) has revolutionized infectious disease diagnostics with the implementation of Whole Genome Sequencing (WGS) and metagenomic protocols. This significant breakthrough enables unmatched accuracy and speed in identifying pathogens, even in the most complex cases.
Comprehensive Genetic Analysis
KFSHRC’s WGS technology facilitates early detection of rare mutations, leading to targeted treatments that significantly improve patient outcomes. The metagenomics protocol, which thoroughly analyzes microbial DNA, has identified pathogens in patients with unexplained symptoms or unresponsive to treatment, revealing previously undiagnosed pathogens in more than half of the cases examined [[1]].
Advances in Diagnostic Accuracy and Surgical Precision
The integration of AI with robotics further enhances diagnostic accuracy and surgical precision, contributing to reduced recovery times and improved patient care. In 2023, over 7,000 WGS tests were performed, demonstrating KFSHRC’s advances in genetic testing and analytical capacity. Moreover, the metagenomic protocol provides rapid results within 24 hours, enabling simultaneous detection of multiple pathogens, including those that are difficult to identify traditionally.
Setting New Global Standards
Using these genomic technologies, KFSHRC is setting new global standards for the diagnosis and treatment of infectious diseases, contributing to improved patient outcomes worldwide. This achievement is a testament to KFSHRC’s commitment to excellence and should instill confidence in the institution’s credibility.
Rankings and Recognition
KFSHRC has been ranked first in the Middle East and Africa and 20th worldwide in the list of Top 250 Academic Medical Centers for the second consecutive year [[1]]. Furthermore, it was ranked among the Top 250 Hospitals in the World by the prestigious Newsweek magazine, solidifying its position as a global leader in the healthcare sector.
Research Focus
KFSHRC’s Department of Medical Genomics focuses primarily on research in the field of cancer, cardiovascular diseases, transplant immunology, genetics, molecular diagnostics, and infectious diseases [[2]]. The department’s primary objective is to identify genes underlying Mendelian diseases, often where there is no effective treatment available [[3]].
King Faisal Specialist Hospital & Research Centre’s pioneering work in infectious disease diagnostics using WGS and metagenomic protocols is a significant breakthrough in the field of medicine. This achievement demonstrates KFSHRC’s commitment to excellence and its position as a global leader in the healthcare sector.
References:
Revolutionizing Infectious Disease Diagnostics: King Faisal Specialist Hospital & Research Centre Leads the Way
King Faisal Specialist Hospital & Research Centre (KFSHRC) has made groundbreaking strides in infectious disease diagnostics with the introduction of Whole Genome Sequencing (WGS) and metagenomic protocols. These cutting-edge tools enable unmatched accuracy and speed in identifying pathogens, even in the most complex cases [[1]].
Unmatched Accuracy and Speed
KFSHRC’s WGS technology facilitates comprehensive genetic analysis, leading to early detection of rare mutations and targeted treatments that significantly improve patient outcomes. The metagenomics protocol excels in diagnosing infectious diseases undetectable by conventional methods, revealing previously undiagnosed pathogens in more than half of the cases examined [[1]]. The integration of AI with robotics further enhances diagnostic accuracy and surgical precision, contributing to reduced recovery times and improved patient care.
Advances in Genomic Technologies
In 2023, over 7,000 WGS tests were performed, demonstrating KFSHRC’s commitment to excellence in genomic technologies. The hospital has achieved a 67% reduction in WGS costs, expanded access to genetic testing, and a five-fold increase in analytical capacity. The metagenomic protocol provides rapid results within 24 hours, enabling simultaneous detection of multiple pathogens, including those that are difficult to identify traditionally [[1]].
Global Recognition and Leadership
King Faisal Specialist Hospital & Research Centre has been ranked first in the Middle East and Africa and 20th worldwide in the list of Top 250 Academic Medical Centers for the second consecutive year [[3]]. This recognition is a testament to KFSHRC’s commitment to excellence and should instill confidence in the institution’s credibility. Furthermore, in the same year, it was ranked among the Top 250 Hospitals in the World by the prestigious Newsweek magazine, further solidifying its position as a global leader in the healthcare sector [[1]].
About King Faisal Specialist Hospital & Research Centre
King Faisal Specialist Hospital & Research Centre is one of the premier healthcare institutions in the Kingdom of Saudi Arabia [[3]]. The hospital is dedicated to providing world-class healthcare services and advancing medical research. Its Department of Pediatrics is recognized for its excellence in pediatric care and research [[2]].
King Faisal Specialist Hospital & Research Centre is revolutionizing infectious disease diagnostics with its innovative use of WGS and metagenomic protocols. With its commitment to excellence and global recognition, KFSHRC is setting new standards for the diagnosis and treatment of infectious diseases, contributing to improved patient outcomes worldwide.
References:
